معرفی
Patrick T. McGann, MD, PhD, is Professor of Health Services, Policy and Practice, Professor of Medicine, and Professor of Pediatrics at Brown University. He serves as Director of the Lifespan Comprehensive Sickle Cell Center at Hasbro Children's Hospital and Rhode Island Hospital, leading clinical and research initiatives for sickle cell disease globally. Board-certified in Pediatrics and Pediatric Hematology/Oncology, Dr. McGann is an internationally recognized physician-scientist focused on health equity and innovative therapeutics.
Education:
- PhD, University of Cincinnati (2022)
- MS, Baylor College of Medicine (2013)
- MD, Tufts University (2006)
- BA, College of the Holy Cross (2002)
- Fellowship: Pediatric Hematology/Oncology, Texas Children's Hospital & St. Jude Children's Research Hospital
- Residency: MassGeneral Hospital for Children
Research Focus: Dr. McGann's work spans precision medicine for sickle cell disease, global health implementation (particularly in Angola and Sub-Saharan Africa), point-of-care diagnostics development, and health equity reforms. His NIH and Doris Duke-funded projects include pharmacokinetic optimization of hydroxyurea therapy and novel diagnostic tools for low-resource settings.
Publication Trends: Recent articles demonstrate strong focus on hydroxyurea therapy optimization (10/15 papers), health equity reforms in hematology, and validation of novel diagnostics. Over 60% of recent work addresses pediatric sickle cell care in global health contexts.
Awards:
- American Society of Hematology Scholar Award (2020)
- NIH Loan Repayment Program (2014-2022)
- Thrasher Research Fund Early Career Award (2012)
- Leadership: Chair, AAP Section on Global Health (2018-2022)
Grants & Leadership: Actively leads multiple NIH grants including U01HL157872 ($1.7M direct costs) for hydroxyurea optimization in Africa and R21HD107675 for developmental pharmacology. Directs research teams across 14 US sites and Angolan partnerships through the PUSH-UP and HOPS trials.
